{
  "calculate_bertscore": [
    {
      "candidate": "EGFR mutations predict response to EGFR TKIs in lung cancer.",
      "reference": "EGFR mutations indicate sensitivity to EGFR tyrosine kinase inhibitors in lung cancer.",
      "expected_score": "Highest"
    },
    {
      "candidate": "Some genetic changes in lung cancer can guide treatment choices.",
      "reference": "EGFR mutations indicate sensitivity to EGFR tyrosine kinase inhibitors in lung cancer.",
      "expected_score": "Medium"
    },
    {
      "candidate": "Chemotherapy is a common treatment for many types of cancer.",
      "reference": "EGFR mutations indicate sensitivity to EGFR tyrosine kinase inhibitors in lung cancer.",
      "expected_score": "Lowest"
    }
  ],
  "fluency_score": [
    {
      "generated_explanation": "BRCA mutations increase cancer risk by impairing DNA repair. This makes cells more susceptible to genomic instability and malignant transformation.",
      "expected_score": "High"
    },
    {
      "generated_explanation": "BRCA mutations make cancer more likely. They affect how cells fix DNA. This can lead to cancer.",
      "expected_score": "Medium"
    },
    {
      "generated_explanation": "BRCA bad. DNA break. Cancer happen.",
      "expected_score": "Low"
    }
  ],
  "semantic_similarity": [
    {
      "text1": "HER2 amplification is a predictive biomarker for trastuzumab in breast cancer.",
      "text2": "HER2 overexpression indicates likely response to HER2-targeted therapies in breast cancer patients.",
      "expected_score": "Highest"
    },
    {
      "text1": "HER2 amplification is a predictive biomarker for trastuzumab in breast cancer.",
      "text2": "Some genetic changes in breast cancer can help guide treatment decisions.",
      "expected_score": "Medium"
    },
    {
      "text1": "HER2 amplification is a predictive biomarker for trastuzumab in breast cancer.",
      "text2": "Regular mammograms are important for early detection of breast cancer.",
      "expected_score": "Lowest"
    }
  ],
  "nli_score": [
    {
      "premise": "KRAS mutations are associated with resistance to EGFR inhibitors in colorectal cancer.",
      "hypothesis": "Patients with KRAS-mutant colorectal cancer are unlikely to benefit from cetuximab treatment.",
      "expected_score": "Highest"
    },
    {
      "premise": "KRAS mutations are associated with resistance to EGFR inhibitors in colorectal cancer.",
      "hypothesis": "Genetic testing is important in colorectal cancer treatment planning.",
      "expected_score": "Medium"
    },
    {
      "premise": "KRAS mutations are associated with resistance to EGFR inhibitors in colorectal cancer.",
      "hypothesis": "All colorectal cancer patients should receive EGFR inhibitors as first-line treatment.",
      "expected_score": "Lowest"
    }
  ],
  "explanation_accuracy_score": [
    {
      "generated_explanation": "PD-L1 expression correlates with response to PD-1/PD-L1 inhibitors.",
      "golden_explanation": "PD-L1 expression levels are associated with increased likelihood of response to PD-1/PD-L1 checkpoint inhibitors.",
      "expected_score": "Highest"
    },
    {
      "generated_explanation": "PD-L1 is a protein that affects how some cancer treatments work.",
      "golden_explanation": "PD-L1 expression levels are associated with increased likelihood of response to PD-1/PD-L1 checkpoint inhibitors.",
      "expected_score": "Medium"
    },
    {
      "generated_explanation": "Chemotherapy kills rapidly dividing cells.",
      "golden_explanation": "PD-L1 expression levels are associated with increased likelihood of response to PD-1/PD-L1 checkpoint inhibitors.",
      "expected_score": "Lowest"
    }
  ],
  "claim_accuracy_score": [
    {
      "claim": "ALK inhibitors are effective in ALK-rearranged NSCLC.",
      "generated_explanation": "ALK inhibitors specifically target the aberrant ALK fusion proteins, leading to tumor cell death in ALK-rearranged NSCLC.",
      "expected_score": "Highest"
    },
    {
      "claim": "ALK inhibitors are effective in ALK-rearranged NSCLC.",
      "generated_explanation": "Targeted therapies can be effective in some types of lung cancer with specific genetic changes.",
      "expected_score": "Medium"
    },
    {
      "claim": "ALK inhibitors are effective in ALK-rearranged NSCLC.",
      "generated_explanation": "Smoking is a major risk factor for developing lung cancer.",
      "expected_score": "Lowest"
    }
  ],
  "claim_support_score": [
    {
      "claim": "ALK inhibitors are effective in ALK-rearranged NSCLC.",
      "generated_explanation": "Clinical trials have shown that ALK inhibitors significantly improve outcomes in patients with ALK-rearranged NSCLC by targeting the ALK fusion gene.",
      "expected_score": "Highest"
    },
    {
      "claim": "ALK inhibitors are effective in ALK-rearranged NSCLC.",
      "generated_explanation": "ALK inhibitors have shown some level of efficacy in various types of cancers that involve genetic mutations.",
      "expected_score": "Medium"
    },
    {
      "claim": "ALK inhibitors are effective in ALK-rearranged NSCLC.",
      "generated_explanation": "ALK inhibitors have virtually no effect regarding ALK-rearranged NSCLC.",
      "expected_score": "Lowest"
    }
  ],  
  "evidence_selection_score": [
    {
      "predicted_evidence_ids": [1, 2, 3, 4],
      "golden_evidence_ids": [1, 2, 3, 4],
      "expected_score": "Highest"
    },
    {
      "predicted_evidence_ids": [1, 2, 3, 5],
      "golden_evidence_ids": [1, 2, 3, 4],
      "expected_score": "Medium"
    },
    {
      "predicted_evidence_ids": [5, 6, 7, 8],
      "golden_evidence_ids": [1, 2, 3, 4],
      "expected_score": "Lowest"
    }
  ],
  "coherence_score": [
    {
        "generated_explanation": "Climate change accelerates due to increased greenhouse gas emissions. This rise in emissions leads to higher global temperatures, causing ice caps to melt. As a result, sea levels rise, threatening coastal communities.",
        "expected_score": "High"
    },
    {
        "generated_explanation": "Greenhouse gases are released into the atmosphere. These gases might affect weather patterns. Some initiatives aim to reduce these emissions.",
        "expected_score": "Medium"
    },
    {
        "generated_explanation": "Climate change is bad. Factories emit gases. Renewable energy exists. Some people deny climate change.",
        "expected_score": "Low"
    }
  ],
  "fact_verification_score": [
    {
      "generated_explanation": "BRCA mutations increase risk of breast and ovarian cancers.",
      "evidence_texts": ["BRCA1 and BRCA2 mutations are associated with higher risk of breast and ovarian cancers.", "Individuals with BRCA mutations often undergo increased cancer screening."],
      "expected_score": "High"
    },
    {
      "generated_explanation": "BRCA mutations increase risk of breast and ovarian cancers.",
      "evidence_texts": ["Genetic factors can influence cancer risk.", "Regular check-ups are important for early cancer detection."],
      "expected_score": "Medium"
    },
    {
      "generated_explanation": "BRCA mutations increase risk of breast and ovarian cancers.",
      "evidence_texts": ["Smoking can be a major cause of lung cancer.", "BRCA mutations affect only some cancers."],
      "expected_score": "Low"
    }
  ],
  "explanation_completeness_score": [
    {
      "generated_explanation": "MSI-H status in colorectal cancer predicts response to immunotherapy. It indicates defective DNA mismatch repair. This leads to increased neoantigen load and T-cell infiltration.",
      "golden_explanation": "Microsatellite instability-high (MSI-H) status in colorectal cancer is predictive of response to immune checkpoint inhibitors. MSI-H tumors have defective DNA mismatch repair, resulting in increased mutational burden and neoantigen production. This promotes T-cell infiltration and susceptibility to immunotherapy.",
      "expected_score": "High"
    },
    {
      "generated_explanation": "MSI-H status in colorectal cancer relates to immunotherapy response. It affects how the immune system interacts with the tumor.",
      "golden_explanation": "Microsatellite instability-high (MSI-H) status in colorectal cancer is predictive of response to immune checkpoint inhibitors. MSI-H tumors have defective DNA mismatch repair, resulting in increased mutational burden and neoantigen production. This promotes T-cell infiltration and susceptibility to immunotherapy.",
      "expected_score": "Medium"
    },
    {
      "generated_explanation": "MSI-H is a feature of some colorectal cancers.",
      "golden_explanation": "Microsatellite instability-high (MSI-H) status in colorectal cancer is predictive of response to immune checkpoint inhibitors. MSI-H tumors have defective DNA mismatch repair, resulting in increased mutational burden and neoantigen production. This promotes T-cell infiltration and susceptibility to immunotherapy.",
      "expected_score": "Low"
    }
  ],
  "evidence_relevance_score": [
    {
      "claim": "PARP inhibitors are effective in BRCA-mutated ovarian cancers.",
      "selected_evidence": ["PARP inhibitors exploit synthetic lethality in BRCA-deficient cells.", "Clinical trials show improved progression-free survival with PARP inhibitors in BRCA-mutated ovarian cancer."],
      "expected_score": "High"
    },
    {
      "claim": "PARP inhibitors are effective in BRCA-mutated ovarian cancers.",
      "selected_evidence": ["Some targeted therapies show promise in ovarian cancer treatment.", "Genetic testing is becoming more common in cancer diagnosis."],
      "expected_score": "Medium"
    },
    {
      "claim": "PARP inhibitors are effective in BRCA-mutated ovarian cancers.",
      "selected_evidence": ["Regular pelvic exams are important for women's health.", "Chemotherapy remains a standard treatment for many cancers."],
      "expected_score": "Low"
    }
  ],
  "claim_evidence_alignment_score": [
    {
      "claim": "IDH mutations in glioma lead to 2-HG accumulation.",
      "selected_evidence": ["IDH1/2 mutations result in neomorphic enzyme activity, producing 2-HG.", "IDH mutantations in gliomas lead to accumulation of 2-HG levels."],
      "expected_score": "High"
    },
    {
      "claim": "IDH mutations in glioma lead to 2-HG accumulation.",
      "selected_evidence": ["IDH mutations can be found in specific types of tumors.", "Genetic alterations sometimes affect metabolism."],
      "expected_score": "Medium"
    },
    {
      "claim": "IDH mutations in glioma lead to 2-HG accumulation.",
      "selected_evidence": ["Gliomas are a type of brain cancer.", "Mutations factors rarely contribute to cancer development."],
      "expected_score": "Low"
    }
  ]
}